Get started
Live feed
ANALYSTRatingvia Quantisnow
Eli Lilly and Company logo

Eli Lilly upgraded by Daiwa Securities with a new price target

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for LLY

Across the 20 sessions after earlier LLY headlines, the stock closed higher 14 times and lower 6 times, with a median move of 1.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

LLY close-to-close change in the session after earlier headlines
SessionEarlier headlineLLYSPY
Dec 15, 2025Goldman reiterated coverage on Eli Lilly with a new price targetand 1 other headline that session+3.4%-0.2%
Dec 12, 2025Updated data for Lilly's Inluriyo™ (imlunestrant) reinforce efficacy results as monotherapy and in combination with Verzenio® (abemaciclib) in ER+, HER2- advanced breast cancer+1.8%-1.1%
Dec 11, 2025Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial+1.6%+0.2%
Dec 9, 2025Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabamaand 1 other headline that session-1.5%-0.1%
Dec 8, 2025Lilly declares first-quarter 2026 dividendand 2 other headlines that session-1.3%-0.3%
Dec 3, 2025U.S. FDA approves expanded indication for Lilly's Jaypirca (pirtobrutinib), the first and only non-covalent (reversible) BTK inhibitor, for adults with relapsed or refractory CLL/SLL previously treated with a covalent BTK inhibitor-1.2%+0.3%
Quantisnow market dataNYSE
Eli Lilly and Company logo
LLY
Eli Lilly and Company
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for LLY

Follow LLY and get a push notification the moment its next story breaks.

Full LLY profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LLY (Eli Lilly and Company) and more on Quantisnow.